Semanteon Capital Management’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Semanteon Capital Management’s Portfolio SWAV Stock Details SWAV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,044	Closed	-$340K	–	337
2024 Q1	$340K	Buy	+1,044	New	+$256K	0.22%	158

Other funds holding SWAV

Sanctuary Advisors Indianapolis, Indiana $18.5B AUM 23.32% 1-Year Est. Return

UWS

Unique Wealth Strategies Burr Ridge, Illinois $275M AUM 29.58% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Semanteon Capital Management's SWAV Position: Q2 2024 in Review

Semanteon Capital Management sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 1,044 shares — an estimated $340K sold.

Semanteon Capital Management first reported a position in SWAV in Q1 2024 and held it in 1 quarter. The position peaked at $340K in Q1 2024. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

Semanteon Capital Management reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Semanteon Capital Management sold 1,044 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $340K.
Semanteon Capital Management first reported a position in Shockwave Medical, Inc. Common Stock in Q1 2024 and held it in 1 quarter.
Semanteon Capital Management's Shockwave Medical, Inc. Common Stock position peaked at $340K in Q1 2024.
7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Semanteon Capital Management's 13F filing for Q2 2024, filed 30 Jul 2024.